NOVO NORDISK (NVO.N) CEO said the company will strengthen its diabetes treatment
business and is creating a new unit focused on hematology and endocrinology.
2026-09-21
NOVO NORDISK (NVO.N) CEO said the company will strengthen its diabetes treatment
business and is creating a new unit focused on hematology and endocrinology.